Human mesenchymal stem cells enhance autophagy of lung carcinoma cells against apoptosis during serum deprivation

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1390-1398

  Zhang, Ming Hui ^a   Hu, Yi De ^a   Xu, Yu ^a   Xiao, Yu ^a   Luo, Yan ^a   Song, Zong Chang ^a   Zhou, Jing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; HMSCs; Lung carcinoma cells; Serum deprivation

Indexed keywords

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MALE; MESENCHYMAL STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; STROMA CELL;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; FURIN; HUMANS; LUNG NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84874623046     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1810     Document Type: Article

References (39)

1. Siegel R, Desantis C, Virgo K, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220-241, 2012.
2. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74, 1997.
3. Young HE, Steele TA, Bray RA, et al: Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec (Hoboken) 264:51-62, 2001.
4. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999.
5. Young HE, Duplaa C, Young TM, et al: Clonogenic analysis reveals reserve stem cells in postnatal mammals: I. Pluripotent mesenchymal stem cells. Anat Rec (Hoboken) 263:350-360, 2001.
6. Fox JM, Chamberlain G, Ashton BA and Middleton J: Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491-502, 2007.
7. Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563, 2007.
8. Mishra PJ, Humeniuk R, Medina DJ, et al: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331-4339, 2008.
9. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-3608, 2002.
10. Xin H, Kanehira M, Mizuguchi H, et al: Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25:1618-1626, 2007.
11. Stagg J: Mesenchymal stem cells in cancer. Stem Cell Rev 4:119-124, 2008.
12. Zhang W: Mesenchymal stem cells in cancer: friends or foes. Cancer Biol Ther 7:252-254, 2008.
13. Bian ZY, Fan QM, Li G, Xu WT and Tang TT: Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Sci 101:2554-2560, 2010.
14. Bagley RG, Weber W, Rouleau C, et al: Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol 34:619-627, 2009.
15. Kato K, Ogura T, Kishimoto A, et al: Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21:6082-6090, 2002.
16. Li Y, Iglehart JD, Richardson AL and Wang ZC: The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy. Autophagy 8:273-274, 2012.
17. Kelekar A: Introduction to the review series Autophagy in Higher Eukaryotes-a matter of survival or death. Autophagy 4:555-556, 2008.
18. Yin L, Kharbanda S and Kufe D: MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol 34:1691-1699, 2009.
19. Carew JS, Medina EC, Esquivel JA II, et al: Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14:2448-2459, 2010.
20. Kang C, You YJ and Avery L: Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation. Genes Dev 21:2161-2171, 2007.
21. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nature reviews. Cancer 7:961-967, 2007.
22. Fujii S, Mitsunaga S, Yamazaki M, et al: Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99:1813-1819, 2008.
23. Dominici M, Le Blanc K, Mueller I, et al: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317, 2006.
24. Rhodes LV, Muir SE, Elliott S, et al: Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res Treat 121:293-300, 2010.
25. Klionsky DJ, Abeliovich H, Agostinis P, et al: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151-175, 2008.
26. Seglen PO and Gordon PB: 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 79:1889-1892, 1982.
27. Sanchez CG, Penfornis P, Oskowitz AZ, et al: Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 32:964-972, 2011.
28. Degenhardt K, Mathew R, Beaudoin B, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10:51-64, 2006.
29. Karantza-Wadsworth V and White E: Role of autophagy in breast cancer. Autophagy 3:610-613, 2007.
30. Lum JJ, Bauer DE, Kong M, et al: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120:237-248, 2005.
31. Karantza-Wadsworth V, Patel S, Kravchuk O, et al: Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21:1621-1635, 2007.
32. Boya P, Gonzalez-Polo RA, Casares N, et al: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025-1040, 2005.
33. Roorda BD, Ter Elst A, Kamps WA and De Bont ES: Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol 69:187-198, 2009.
34. Tian LL, Yue W, Zhu F, Li S and Li W: Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol 226:1860-1867, 2011.
35. Sinha S and Levine B: The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27(Suppl 1):S137-S148, 2008.
36. Maiuri MC, Criollo A, Tasdemir E, et al: BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X (L). Autophagy 3:374-376, 2007.
37. Pattingre S, Tassa A, Qu X, et al: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927-939, 2005.
38. Chang NC, Nguyen M, Germain M and Shore GC: Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J 29:606-618, 2010.
39. Lian J, Wu X, He F, et al: A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 18:60-71, 2011.